Key Takeaways
-
Combining microneedling with minoxidil significantly increases hair count — this meta-analysis of 10 randomised controlled trials (466 patients) found the combination produced a large, statistically significant improvement in total hair count compared to minoxidil alone (SMD 1.76, P < 0.00001).
-
Hair count improves, but hair thickness may not — while the combination dramatically increased the number of hairs, the evidence did not confirm a significant increase in hair diameter (SMD 0.82, P = 0.05), suggesting the primary benefit is growing new hairs rather than thickening existing ones.
-
The treatment is safe — no scarring or serious adverse events were reported across any of the 10 included studies, confirming the safety profile of microneedling combined with topical minoxidil.
-
This confirms and strengthens earlier findings — as a 2023 meta-analysis, this study incorporates more recent trials than the 2022 Gupta meta-analysis and reaches the same conclusion: microneedling plus minoxidil is superior to minoxidil alone.
-
Pre-registered and PRISMA-compliant — the study was registered on PROSPERO and INPLASY before conducting the analysis, reducing the risk of selective reporting bias.
Evidence at a Glance
| Evidence Level |
Level 1a — Systematic review and meta-analysis of randomised controlled trials |
| Studies Included |
10 RCTs (8 included in quantitative meta-analysis) |
| Total Patients |
466 patients across all included studies |
| Key Result |
SMD 1.76 for hair count (95% CI: 1.26–2.26, P < 0.00001) |
| Secondary Result |
SMD 0.82 for hair diameter (95% CI: −0.01 to 1.65, P = 0.05 — not significant) |
| Safety |
No scarring or serious adverse events in any study |
About This Study
| Authors |
Parsa Abdi, Christian Awad, Michelle R. Anthony, Christopher Farkouh, Bret Kenny, Howard I. Maibach, Boluwaji Ogunyemi |
| Journal |
Archives of Dermatological Research |
| Year |
2023 (published online September 4, 2023) |
| Volume/Pages |
Vol. 315, Issue 10, pp. 2775–2785 |
| Type |
Systematic review and meta-analysis |
| PMID |
37665358 |
| DOI |
10.1007/s00403-023-02688-1 |
| Registration |
PROSPERO CRD42023391164 & INPLASY202310031 |
| Full Paper |
View on PubMed → |
Note: This is a plain-language summary of the published research paper. The original study was conducted independently and is not affiliated with Hairgenetix. We present this summary to make scientific research more accessible to people experiencing hair loss.
Reviewed by: Esther Bodde, MSc — Health Scientist and Medical Research Analyst at Hairgenetix. Esther holds a Master of Science degree and specialises in translating clinical research into clear, evidence-based consumer information. This summary was reviewed for scientific accuracy, fair representation of results, and clear communication of study limitations.
Why This Research Matters
By 2023, multiple individual clinical trials had shown that adding microneedling to a minoxidil regimen produced better results than minoxidil alone. But individual trials — even well-designed ones — can be affected by their specific patient populations, methods, or sample sizes. The real question was: when you pool all the evidence together, does the combination still hold up?
This is exactly what Abdi and colleagues set out to answer. Their systematic review and meta-analysis identified every available randomised controlled trial comparing microneedling plus minoxidil against minoxidil alone, then statistically combined the results. With 10 RCTs and 466 patients, this represents one of the most comprehensive analyses of this specific treatment combination.
The answer was unambiguous: a P-value of less than 0.00001 means the probability that this result occurred by chance is less than 1 in 100,000. The combination works, and the evidence is now overwhelming.
What makes this meta-analysis particularly credible is that it was pre-registered on two independent platforms (PROSPERO and INPLASY) before the analysis was conducted. Pre-registration prevents researchers from selectively reporting only favourable outcomes — it commits them to analysing specific endpoints before they know what the data will show.
What The Researchers Did
Abdi and colleagues conducted a systematic literature search across four major medical databases — Scopus, Cochrane Library, Embase, and PubMed (the US National Library of Medicine) — to identify all randomised controlled trials that tested microneedling combined with topical minoxidil against minoxidil monotherapy for androgenetic alopecia.
Their search and selection process followed PRISMA guidelines — the internationally accepted standard for conducting and reporting systematic reviews. Two independent reviewers screened studies, extracted data, and assessed the risk of bias using the Cochrane risk of bias assessment tool (the gold standard for evaluating RCT quality).
From the initial search, 10 RCTs met the inclusion criteria and were included in the qualitative review. Of these, 8 studies provided sufficient quantitative data for inclusion in the statistical meta-analysis. The pooled analysis examined two primary outcomes:
-
Total hair count — the number of hairs in a standardised scalp area, measured before and after treatment
-
Hair diameter — the thickness of individual hair shafts, indicating whether existing hairs were becoming thicker or remaining unchanged
Understanding the Research Methods
What is a meta-analysis and why does it matter? A meta-analysis statistically combines results from multiple independent studies to produce a single, more powerful estimate of a treatment's effect. Think of it like asking 10 different research teams the same question and then mathematically combining their answers. If they all point in the same direction, you can be much more confident in the conclusion than from any single study alone.
What does SMD (Standard Mean Difference) mean? When different studies measure hair count using slightly different methods or scales, you can't simply average the raw numbers. SMD converts all results onto a common scale by expressing each study's treatment effect as a proportion of its own variability. An SMD of 0.2 is considered a small effect, 0.5 is medium, and 0.8 or above is large. The SMD of 1.76 found in this analysis is a very large effect — nearly double the threshold for "large."
What does P < 0.00001 mean? The P-value represents the probability that the observed result could have occurred by random chance alone, assuming the treatment had no real effect. P < 0.00001 means there is less than a 1 in 100,000 chance that this result is a statistical fluke. In medical research, P < 0.05 (1 in 20) is the standard threshold for "statistically significant." This result exceeds that threshold by orders of magnitude.
Why pre-register a study? Pre-registration on platforms like PROSPERO means the researchers publicly committed to their analysis plan before seeing the results. This prevents "data dredging" — the problematic practice of running many analyses and only reporting the ones that look favourable. It's a hallmark of transparent, trustworthy research.
What They Found
Dramatic increase in hair count: Across all 8 studies in the quantitative analysis, microneedling combined with minoxidil produced a standardised mean difference of 1.76 (95% CI: 1.26–2.26, P < 0.00001) in total hair count compared to minoxidil alone. This is classified as a "very large" effect size and represents one of the strongest treatment effects seen in hair loss research.
Hair diameter: trending but not significant: The analysis showed a trend toward increased hair diameter with the combination treatment (SMD 0.82, 95% CI: −0.01 to 1.65), but the P-value of 0.05 fell exactly at the conventional threshold for statistical significance. This suggests the combination may help thicken existing hairs, but the current evidence isn't strong enough to confirm this with certainty.
Excellent safety profile: Across all 10 included trials, no cases of scarring or serious adverse events were reported with the microneedling and minoxidil combination. This comprehensive safety data across 466 patients provides strong reassurance about the tolerability of this approach.
Consistent across studies: All 8 studies included in the hair count analysis showed the same direction of effect — the combination was superior to minoxidil alone in every single trial. This consistency across different research groups, countries, and patient populations makes the conclusion particularly robust.
Figure 1: Summary of meta-analysis findings from Abdi et al. (2023). Left: effect sizes (SMD) for hair count and hair diameter outcomes. Centre: P-value comparison showing the strength of statistical significance. Right: study characteristics and safety summary across all included trials. Data source: Archives of Dermatological Research 2023;315:2775-2785.
Why Microneedling and Minoxidil Work Better Together
Enhanced drug penetration: Microneedling creates thousands of tiny channels in the scalp's outer barrier (stratum corneum). These micro-channels dramatically increase the absorption of topically applied minoxidil, allowing more of the active ingredient to reach the hair follicle's dermal papilla where it exerts its growth-stimulating effects. Studies have shown that microneedling can increase topical drug absorption by 100-fold or more.
Growth factor activation: The controlled micro-injuries from microneedling trigger a wound-healing cascade that releases platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF). These growth factors independently stimulate hair follicle stem cells and promote the transition from the resting phase (telogen) to the active growth phase (anagen).
Wnt/β-catenin pathway activation: Microneedling has been shown to upregulate the Wnt/β-catenin signalling pathway — a critical biological switch that controls hair follicle development and cycling. This pathway activation promotes hair follicle neogenesis (the formation of new follicles) and can help miniaturised follicles return to producing thicker, terminal hairs.
Complementary mechanisms: Minoxidil works primarily as a vasodilator, increasing blood flow to the follicle, and as a potassium channel opener that extends the growth phase of the hair cycle. Microneedling works through physical stimulation and growth factor release. Because these mechanisms are different and complementary, the combined effect is greater than either alone — which is exactly what this meta-analysis confirms.
Clinical Interpretation
This meta-analysis provides Level 1a evidence — the highest tier in the evidence hierarchy — that microneedling enhances the effectiveness of topical minoxidil for androgenetic alopecia. Several aspects of these findings deserve careful interpretation:
The effect size is remarkably large: An SMD of 1.76 is well beyond the 0.8 threshold typically considered a "large" effect in medical research. To put this in practical terms: the average person receiving the combination treatment showed more hair regrowth than approximately 96% of people receiving minoxidil alone. This is an exceptionally strong treatment effect.
The hair diameter question: The borderline non-significant result for hair diameter (P = 0.05) is worth understanding. It suggests that the combination primarily works by stimulating new hair growth (increasing hair count) rather than by thickening existing miniaturised hairs. However, the trend is positive. With more studies and larger sample sizes, this outcome may reach significance. The Xu 2024 meta-analysis found similar patterns.
Practical confidence: The fact that this finding was consistent across all 8 quantitative studies — conducted by different teams in different countries — provides exceptional confidence. In medicine, a result that replicates consistently across independent studies is considered highly reliable.
How This Compares With Other Meta-Analyses
| Meta-Analysis |
Studies Pooled |
Key Finding |
Conclusion |
| Abdi 2023 (this study) |
10 RCTs, 466 patients |
SMD 1.76 for hair count (P < 0.00001) |
Combination strongly superior to minoxidil alone |
| Gupta 2022 |
Multiple trials pooled |
β = 12.29 (P < 0.001) for MN vs minoxidil |
Microneedling alone outperforms minoxidil; combination best |
| Xu 2024 |
8 RCTs, 472 patients |
SMD 15.82 for hair count; diameter not significant |
Combination effective; depth <1mm slightly better than >1mm |
| Pei 2024 |
12 RCTs |
MN + topical superior across multiple outcome measures |
Strong support for combined approach |
The remarkable consistency across four independent meta-analyses — conducted by different research teams using slightly different methodologies — all reaching the same conclusion represents a convergence of evidence that is exceptionally rare in dermatology research. The case for combining microneedling with topical treatment is now supported by the strongest possible level of evidence.
Treatment Parameters Across Included Studies
| Topical Agent |
Minoxidil (typically 5% for men, 2% for women) |
| Microneedling Device |
Derma roller or dermapen (varied across studies) |
| Needle Depth |
Ranged from 0.5mm to 2.5mm across included studies |
| Microneedling Frequency |
Weekly to biweekly (most commonly weekly) |
| Treatment Duration |
12 to 24 weeks across included studies |
| Application Timing |
Minoxidil applied after microneedling (typically 24 hours post-session or immediately, depending on protocol) |
Important context: Because this is a meta-analysis pooling data from multiple studies, the included trials used varying protocols. The Xu 2024 meta-analysis provides more specific subgroup analysis by needle depth and duration. For at-home microneedling, most dermatologists recommend a 0.5mm to 1.0mm derma roller used once weekly, with topical products applied 24 hours after the microneedling session to allow the micro-channels to close.
Research Limitations to Consider
-
Protocol heterogeneity: The included studies used different needle depths, microneedling frequencies, minoxidil concentrations, and treatment durations. While the overall result is clear, this variability means the meta-analysis cannot identify the single "best" protocol.
-
Limited long-term data: Most included studies lasted 12 to 24 weeks. The long-term durability of the combined treatment effect — and whether maintenance microneedling is needed — is not well established.
-
Hair diameter borderline result: The non-significant finding for hair diameter (P = 0.05) suggests the combination may not substantially thicken existing hairs. People expecting miniaturised hairs to become dramatically thicker should temper expectations — the primary benefit appears to be growing more hairs.
-
Predominantly male participants: Most studies in this meta-analysis enrolled men with male pattern hair loss. While the biological mechanisms apply to both sexes, the magnitude of benefit may differ for female pattern hair loss.
-
Blinding challenges: It's difficult to blind microneedling studies because patients can feel the needling procedure. This means some of the observed benefit could be influenced by placebo effects, though the consistency across studies mitigates this concern.
-
Publication bias possibility: Studies showing positive results are more likely to be published than negative ones. While the pre-registration and systematic search methods reduce this concern, it cannot be entirely eliminated.
What This Means For Your Hair
This meta-analysis provides the clearest evidence yet that if you're using minoxidil for hair loss, adding microneedling to your routine will likely improve your results. Here are the practical takeaways:
-
Microneedling is the most evidence-backed addition to minoxidil: With four independent meta-analyses now confirming the benefit, microneedling has more supporting evidence than any other complementary treatment for androgenetic alopecia. If you're choosing one thing to add to your minoxidil routine, this should be it.
-
The benefit is in growing more hair, not thicker hair: This meta-analysis (and the Xu 2024 analysis) suggest the primary mechanism is stimulating new hair growth rather than dramatically thickening existing miniaturised hairs. Expect to see more hairs appearing, particularly in areas where follicles are still present but dormant.
-
Safety is well-established: Across 466 patients in controlled trials, no serious adverse events occurred. Microneedling, when performed correctly, is safe — but it does require proper technique and hygiene to avoid infection.
-
Enhanced delivery applies to all topical treatments: While this meta-analysis specifically examined minoxidil, the micro-channel delivery mechanism works for any topical active ingredient. This is why combining microneedling with copper peptide serums — which have their own independent evidence base for hair growth — follows the same scientific principle.
-
Consistency matters more than intensity: The included studies used protocols ranging from 12 to 24 weeks. Hair growth is a slow biological process. Setting a realistic, consistent weekly routine is more important than aggressive needling depth or frequency.
Key Terms Explained
- Meta-Analysis
- A statistical method that combines results from multiple independent studies on the same topic. It's considered the highest level of evidence in medical research because it pools data from many sources, making conclusions more robust than any single study. This meta-analysis combined 10 RCTs involving 466 patients.
- Randomised Controlled Trial (RCT)
- A study design where participants are randomly assigned to receive either the treatment being tested or a control (placebo or standard treatment). Randomisation ensures that differences between groups are due to the treatment rather than pre-existing differences between patients. RCTs are considered the gold standard for testing treatments.
- Standard Mean Difference (SMD)
- A statistical measure that expresses the size of a treatment effect on a common scale, allowing comparison across studies that used different measurement methods. An SMD below 0.2 is small, 0.5 is medium, 0.8 is large, and 1.76 (as found here) is very large.
- 95% Confidence Interval (CI)
- A range of values within which the true treatment effect is likely to fall. The 95% CI of 1.26–2.26 for hair count means we can be 95% confident that the true effect lies between these values. When the CI doesn't cross zero, the result is statistically significant.
- PRISMA Guidelines
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses — an internationally accepted checklist that ensures systematic reviews are conducted transparently and completely. Following PRISMA means the researchers documented every step of their search, selection, and analysis process.
- PROSPERO Registration
- An international database where researchers publicly register their systematic review protocols before conducting the review. This pre-registration prevents selective reporting and increases the credibility of the findings.
- Cochrane Risk of Bias Tool
- The standard method for assessing the quality of randomised controlled trials. It evaluates potential sources of bias including randomisation procedures, blinding, incomplete data handling, and selective reporting. Two independent reviewers assessed each study in this meta-analysis.
- P-value
- The probability that the observed result could have occurred by chance alone if the treatment had no real effect. A P-value below 0.05 (5% chance) is the conventional threshold for statistical significance. The P < 0.00001 found for hair count means there's less than a 1 in 100,000 chance the result is a statistical fluke.
Further Reading
For more peer-reviewed studies on hair loss and copper peptide therapy, see our full research hub.
Frequently Asked Questions
How does this differ from the Gupta 2022 meta-analysis?
While both meta-analyses examine microneedling for hair loss, they approach the question differently. Gupta 2022 used multivariable regression analysis to compare microneedling (with and without minoxidil) against minoxidil alone, finding that microneedling alone outperformed minoxidil. Abdi 2023 specifically focused on the combination of microneedling plus minoxidil versus minoxidil alone, using standard mean difference as its effect measure. Being a year more recent, Abdi 2023 also includes newer trials in its analysis. Both reach the same fundamental conclusion: adding microneedling to minoxidil produces superior results.
Why didn't hair diameter reach statistical significance?
The P-value of 0.05 for hair diameter falls right at the conventional threshold for significance — it's a borderline result that could go either way with additional data. The wide confidence interval (−0.01 to 1.65) suggests high variability between studies in this outcome. Several explanations are possible: microneedling may primarily stimulate new follicle activation (increasing count) rather than reversing miniaturisation of existing follicles (increasing diameter); the measurement methods for diameter may be less consistent across studies; or the studies may simply have been underpowered to detect a real but smaller effect on diameter. The Xu 2024 meta-analysis found a similar pattern.
What needle depth should I use at home?
This meta-analysis included studies using needle depths ranging from 0.5mm to 2.5mm and found benefits across the range, so it cannot identify the single "best" depth. However, the Xu 2024 meta-analysis performed subgroup analysis and found that depths below 1mm (SMD 1.16) showed slightly better effect sizes than depths above 1mm (SMD 0.52). For at-home use, most dermatologists recommend 0.5mm to 1.0mm — deep enough to stimulate growth factors and create micro-channels for topical penetration, but shallow enough to be safe and tolerable without professional supervision.
How long until I see results from combining microneedling with topical treatments?
The studies included in this meta-analysis ranged from 12 to 24 weeks in duration, with most showing statistically significant improvements by 12 weeks. However, hair biology means that visible changes typically become noticeable at 8–12 weeks, with continued improvement through 24 weeks and beyond. The hair growth cycle means that newly stimulated follicles need time to produce visible hairs. Most dermatologists advise committing to at least 3–6 months of consistent treatment before evaluating results.
Can I use copper peptide serum instead of minoxidil with microneedling?
This meta-analysis specifically examined the combination of microneedling with minoxidil, so it doesn't directly answer this question. However, the underlying mechanism — microneedling creating channels that enhance topical absorption plus the independent growth factor stimulation from micro-injuries — applies to any topical active ingredient. Copper peptides (GHK-Cu) have their own independent evidence base showing hair growth stimulation through different mechanisms than minoxidil. Using microneedling with copper peptide serums follows the same scientific principle validated in this meta-analysis, though combination-specific meta-analyses for GHK-Cu don't yet exist.
Is this treatment effective for women?
Most studies included in this meta-analysis enrolled predominantly male participants with male pattern hair loss (androgenetic alopecia). While the biological mechanisms — enhanced drug penetration, growth factor release, Wnt pathway activation — are not gender-specific, the evidence base for women is smaller. Female pattern hair loss involves some different hormonal dynamics, and the pattern of thinning differs. Minoxidil is approved for female hair loss (at 2% concentration), and the mechanistic rationale for adding microneedling applies equally, but women should consult a dermatologist familiar with female hair loss before starting any combined protocol.
What does "pre-registered" mean and why does it matter?
Pre-registration means the researchers publicly documented their analysis plan — including which studies they would include, what outcomes they would measure, and how they would analyse the data — before they actually conducted the analysis. This was done on two platforms: PROSPERO (the international register for systematic reviews) and INPLASY. Pre-registration matters because it prevents researchers from running multiple analyses and only reporting the ones that show positive results. It's essentially a promise to report the findings regardless of whether they support the hypothesis — which makes the positive results more trustworthy.
Should I stop minoxidil and just do microneedling instead?
No — the evidence from this and other meta-analyses consistently shows that the combination of microneedling plus minoxidil is superior to either treatment alone. The Gupta 2022 meta-analysis did find that microneedling alone can outperform minoxidil alone, but the best results come from using both together. The two treatments work through different, complementary mechanisms: minoxidil extends the growth phase and increases blood flow, while microneedling stimulates growth factors and enhances drug penetration. Dropping either one means losing part of the therapeutic benefit.
Original Study Citation
Abdi, P., Awad, C., Anthony, M. R., Farkouh, C., Kenny, B., Maibach, H. I., & Ogunyemi, B. (2023). Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis. Archives of Dermatological Research, 315(10), 2775–2785. https://doi.org/10.1007/s00403-023-02688-1
How to Cite This Summary
APA: Hairgenetix. (2025). Minoxidil + microneedling: Another meta-analysis confirms the combination works — Plain-language study summary. Hairgenetix Research Library. https://hairgenetix.com/blogs/articles/minoxidil-microneedling-meta-analysis-abdi-2023
Informal: A 2023 meta-analysis of 10 RCTs (466 patients) found that combining microneedling with minoxidil produced a very large treatment effect on hair count (SMD 1.76, P < 0.00001) with no serious adverse events (Abdi et al., 2023). Summarised by Hairgenetix at hairgenetix.com.
Last reviewed and updated: March 2025 · Based on original publication: September 2023
The Science Behind the Hairgenetix Protocol
This meta-analysis — along with three other independent meta-analyses — confirms that microneedling dramatically enhances the effectiveness of topical hair loss treatments. Four separate research teams, pooling data from dozens of clinical trials, have reached the same conclusion.
The Hairgenetix system is built on this evidence. Our medical-grade derma roller creates the micro-channels that research shows enhance topical absorption by up to 100-fold, while our copper peptide serum provides scientifically studied active ingredients designed to take advantage of that enhanced delivery.
Browse the Hairgenetix Collection →
Minoxidil + Microneedling: Another Meta-Analysis Confirms the Combination Works (2023)
Key Takeaways
Evidence at a Glance
About This Study
Why This Research Matters
By 2023, multiple individual clinical trials had shown that adding microneedling to a minoxidil regimen produced better results than minoxidil alone. But individual trials — even well-designed ones — can be affected by their specific patient populations, methods, or sample sizes. The real question was: when you pool all the evidence together, does the combination still hold up?
This is exactly what Abdi and colleagues set out to answer. Their systematic review and meta-analysis identified every available randomised controlled trial comparing microneedling plus minoxidil against minoxidil alone, then statistically combined the results. With 10 RCTs and 466 patients, this represents one of the most comprehensive analyses of this specific treatment combination.
The answer was unambiguous: a P-value of less than 0.00001 means the probability that this result occurred by chance is less than 1 in 100,000. The combination works, and the evidence is now overwhelming.
What makes this meta-analysis particularly credible is that it was pre-registered on two independent platforms (PROSPERO and INPLASY) before the analysis was conducted. Pre-registration prevents researchers from selectively reporting only favourable outcomes — it commits them to analysing specific endpoints before they know what the data will show.
What The Researchers Did
Abdi and colleagues conducted a systematic literature search across four major medical databases — Scopus, Cochrane Library, Embase, and PubMed (the US National Library of Medicine) — to identify all randomised controlled trials that tested microneedling combined with topical minoxidil against minoxidil monotherapy for androgenetic alopecia.
Their search and selection process followed PRISMA guidelines — the internationally accepted standard for conducting and reporting systematic reviews. Two independent reviewers screened studies, extracted data, and assessed the risk of bias using the Cochrane risk of bias assessment tool (the gold standard for evaluating RCT quality).
From the initial search, 10 RCTs met the inclusion criteria and were included in the qualitative review. Of these, 8 studies provided sufficient quantitative data for inclusion in the statistical meta-analysis. The pooled analysis examined two primary outcomes:
Understanding the Research Methods
What is a meta-analysis and why does it matter? A meta-analysis statistically combines results from multiple independent studies to produce a single, more powerful estimate of a treatment's effect. Think of it like asking 10 different research teams the same question and then mathematically combining their answers. If they all point in the same direction, you can be much more confident in the conclusion than from any single study alone.
What does SMD (Standard Mean Difference) mean? When different studies measure hair count using slightly different methods or scales, you can't simply average the raw numbers. SMD converts all results onto a common scale by expressing each study's treatment effect as a proportion of its own variability. An SMD of 0.2 is considered a small effect, 0.5 is medium, and 0.8 or above is large. The SMD of 1.76 found in this analysis is a very large effect — nearly double the threshold for "large."
What does P < 0.00001 mean? The P-value represents the probability that the observed result could have occurred by random chance alone, assuming the treatment had no real effect. P < 0.00001 means there is less than a 1 in 100,000 chance that this result is a statistical fluke. In medical research, P < 0.05 (1 in 20) is the standard threshold for "statistically significant." This result exceeds that threshold by orders of magnitude.
Why pre-register a study? Pre-registration on platforms like PROSPERO means the researchers publicly committed to their analysis plan before seeing the results. This prevents "data dredging" — the problematic practice of running many analyses and only reporting the ones that look favourable. It's a hallmark of transparent, trustworthy research.
What They Found
Figure 1: Summary of meta-analysis findings from Abdi et al. (2023). Left: effect sizes (SMD) for hair count and hair diameter outcomes. Centre: P-value comparison showing the strength of statistical significance. Right: study characteristics and safety summary across all included trials. Data source: Archives of Dermatological Research 2023;315:2775-2785.
Why Microneedling and Minoxidil Work Better Together
Enhanced drug penetration: Microneedling creates thousands of tiny channels in the scalp's outer barrier (stratum corneum). These micro-channels dramatically increase the absorption of topically applied minoxidil, allowing more of the active ingredient to reach the hair follicle's dermal papilla where it exerts its growth-stimulating effects. Studies have shown that microneedling can increase topical drug absorption by 100-fold or more.
Growth factor activation: The controlled micro-injuries from microneedling trigger a wound-healing cascade that releases platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF). These growth factors independently stimulate hair follicle stem cells and promote the transition from the resting phase (telogen) to the active growth phase (anagen).
Wnt/β-catenin pathway activation: Microneedling has been shown to upregulate the Wnt/β-catenin signalling pathway — a critical biological switch that controls hair follicle development and cycling. This pathway activation promotes hair follicle neogenesis (the formation of new follicles) and can help miniaturised follicles return to producing thicker, terminal hairs.
Complementary mechanisms: Minoxidil works primarily as a vasodilator, increasing blood flow to the follicle, and as a potassium channel opener that extends the growth phase of the hair cycle. Microneedling works through physical stimulation and growth factor release. Because these mechanisms are different and complementary, the combined effect is greater than either alone — which is exactly what this meta-analysis confirms.
Clinical Interpretation
This meta-analysis provides Level 1a evidence — the highest tier in the evidence hierarchy — that microneedling enhances the effectiveness of topical minoxidil for androgenetic alopecia. Several aspects of these findings deserve careful interpretation:
The effect size is remarkably large: An SMD of 1.76 is well beyond the 0.8 threshold typically considered a "large" effect in medical research. To put this in practical terms: the average person receiving the combination treatment showed more hair regrowth than approximately 96% of people receiving minoxidil alone. This is an exceptionally strong treatment effect.
The hair diameter question: The borderline non-significant result for hair diameter (P = 0.05) is worth understanding. It suggests that the combination primarily works by stimulating new hair growth (increasing hair count) rather than by thickening existing miniaturised hairs. However, the trend is positive. With more studies and larger sample sizes, this outcome may reach significance. The Xu 2024 meta-analysis found similar patterns.
Practical confidence: The fact that this finding was consistent across all 8 quantitative studies — conducted by different teams in different countries — provides exceptional confidence. In medicine, a result that replicates consistently across independent studies is considered highly reliable.
How This Compares With Other Meta-Analyses
The remarkable consistency across four independent meta-analyses — conducted by different research teams using slightly different methodologies — all reaching the same conclusion represents a convergence of evidence that is exceptionally rare in dermatology research. The case for combining microneedling with topical treatment is now supported by the strongest possible level of evidence.
Treatment Parameters Across Included Studies
Important context: Because this is a meta-analysis pooling data from multiple studies, the included trials used varying protocols. The Xu 2024 meta-analysis provides more specific subgroup analysis by needle depth and duration. For at-home microneedling, most dermatologists recommend a 0.5mm to 1.0mm derma roller used once weekly, with topical products applied 24 hours after the microneedling session to allow the micro-channels to close.
Research Limitations to Consider
What This Means For Your Hair
This meta-analysis provides the clearest evidence yet that if you're using minoxidil for hair loss, adding microneedling to your routine will likely improve your results. Here are the practical takeaways:
Key Terms Explained
Further Reading
For more peer-reviewed studies on hair loss and copper peptide therapy, see our full research hub.
Frequently Asked Questions
How does this differ from the Gupta 2022 meta-analysis?
While both meta-analyses examine microneedling for hair loss, they approach the question differently. Gupta 2022 used multivariable regression analysis to compare microneedling (with and without minoxidil) against minoxidil alone, finding that microneedling alone outperformed minoxidil. Abdi 2023 specifically focused on the combination of microneedling plus minoxidil versus minoxidil alone, using standard mean difference as its effect measure. Being a year more recent, Abdi 2023 also includes newer trials in its analysis. Both reach the same fundamental conclusion: adding microneedling to minoxidil produces superior results.
Why didn't hair diameter reach statistical significance?
The P-value of 0.05 for hair diameter falls right at the conventional threshold for significance — it's a borderline result that could go either way with additional data. The wide confidence interval (−0.01 to 1.65) suggests high variability between studies in this outcome. Several explanations are possible: microneedling may primarily stimulate new follicle activation (increasing count) rather than reversing miniaturisation of existing follicles (increasing diameter); the measurement methods for diameter may be less consistent across studies; or the studies may simply have been underpowered to detect a real but smaller effect on diameter. The Xu 2024 meta-analysis found a similar pattern.
What needle depth should I use at home?
This meta-analysis included studies using needle depths ranging from 0.5mm to 2.5mm and found benefits across the range, so it cannot identify the single "best" depth. However, the Xu 2024 meta-analysis performed subgroup analysis and found that depths below 1mm (SMD 1.16) showed slightly better effect sizes than depths above 1mm (SMD 0.52). For at-home use, most dermatologists recommend 0.5mm to 1.0mm — deep enough to stimulate growth factors and create micro-channels for topical penetration, but shallow enough to be safe and tolerable without professional supervision.
How long until I see results from combining microneedling with topical treatments?
The studies included in this meta-analysis ranged from 12 to 24 weeks in duration, with most showing statistically significant improvements by 12 weeks. However, hair biology means that visible changes typically become noticeable at 8–12 weeks, with continued improvement through 24 weeks and beyond. The hair growth cycle means that newly stimulated follicles need time to produce visible hairs. Most dermatologists advise committing to at least 3–6 months of consistent treatment before evaluating results.
Can I use copper peptide serum instead of minoxidil with microneedling?
This meta-analysis specifically examined the combination of microneedling with minoxidil, so it doesn't directly answer this question. However, the underlying mechanism — microneedling creating channels that enhance topical absorption plus the independent growth factor stimulation from micro-injuries — applies to any topical active ingredient. Copper peptides (GHK-Cu) have their own independent evidence base showing hair growth stimulation through different mechanisms than minoxidil. Using microneedling with copper peptide serums follows the same scientific principle validated in this meta-analysis, though combination-specific meta-analyses for GHK-Cu don't yet exist.
Is this treatment effective for women?
Most studies included in this meta-analysis enrolled predominantly male participants with male pattern hair loss (androgenetic alopecia). While the biological mechanisms — enhanced drug penetration, growth factor release, Wnt pathway activation — are not gender-specific, the evidence base for women is smaller. Female pattern hair loss involves some different hormonal dynamics, and the pattern of thinning differs. Minoxidil is approved for female hair loss (at 2% concentration), and the mechanistic rationale for adding microneedling applies equally, but women should consult a dermatologist familiar with female hair loss before starting any combined protocol.
What does "pre-registered" mean and why does it matter?
Pre-registration means the researchers publicly documented their analysis plan — including which studies they would include, what outcomes they would measure, and how they would analyse the data — before they actually conducted the analysis. This was done on two platforms: PROSPERO (the international register for systematic reviews) and INPLASY. Pre-registration matters because it prevents researchers from running multiple analyses and only reporting the ones that show positive results. It's essentially a promise to report the findings regardless of whether they support the hypothesis — which makes the positive results more trustworthy.
Should I stop minoxidil and just do microneedling instead?
No — the evidence from this and other meta-analyses consistently shows that the combination of microneedling plus minoxidil is superior to either treatment alone. The Gupta 2022 meta-analysis did find that microneedling alone can outperform minoxidil alone, but the best results come from using both together. The two treatments work through different, complementary mechanisms: minoxidil extends the growth phase and increases blood flow, while microneedling stimulates growth factors and enhances drug penetration. Dropping either one means losing part of the therapeutic benefit.
Original Study Citation
Abdi, P., Awad, C., Anthony, M. R., Farkouh, C., Kenny, B., Maibach, H. I., & Ogunyemi, B. (2023). Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis. Archives of Dermatological Research, 315(10), 2775–2785. https://doi.org/10.1007/s00403-023-02688-1
How to Cite This Summary
APA: Hairgenetix. (2025). Minoxidil + microneedling: Another meta-analysis confirms the combination works — Plain-language study summary. Hairgenetix Research Library. https://hairgenetix.com/blogs/articles/minoxidil-microneedling-meta-analysis-abdi-2023
Informal: A 2023 meta-analysis of 10 RCTs (466 patients) found that combining microneedling with minoxidil produced a very large treatment effect on hair count (SMD 1.76, P < 0.00001) with no serious adverse events (Abdi et al., 2023). Summarised by Hairgenetix at hairgenetix.com.
Related Research on Hairgenetix
The Science Behind the Hairgenetix Protocol
This meta-analysis — along with three other independent meta-analyses — confirms that microneedling dramatically enhances the effectiveness of topical hair loss treatments. Four separate research teams, pooling data from dozens of clinical trials, have reached the same conclusion.
The Hairgenetix system is built on this evidence. Our medical-grade derma roller creates the micro-channels that research shows enhance topical absorption by up to 100-fold, while our copper peptide serum provides scientifically studied active ingredients designed to take advantage of that enhanced delivery.
Browse the Hairgenetix Collection →